Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review
Publication
, Journal Article
Vannappagari, V; Ragone, L; Henegar, C; van Wyk, J; Brown, D; Demarest, J; Quercia, R; Clair, MS; Underwood, M; Gatell, JM; de Ruiter, A; Aboud, M
Published in: Antiviral Therapy
August 2019
Duke Scholars
Published In
Antiviral Therapy
DOI
EISSN
2040-2058
ISSN
1359-6535
Publication Date
August 2019
Volume
24
Issue
6
Start / End Page
393 / 404
Publisher
SAGE Publications
Related Subject Headings
- Virology
- 1108 Medical Microbiology
- 1103 Clinical Sciences
- 0605 Microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Vannappagari, V., Ragone, L., Henegar, C., van Wyk, J., Brown, D., Demarest, J., … Aboud, M. (2019). Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy, 24(6), 393–404. https://doi.org/10.3851/imp3331
Vannappagari, Vani, Leigh Ragone, Cassidy Henegar, Jean van Wyk, Dannae Brown, James Demarest, Romina Quercia, et al. “Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review.” Antiviral Therapy 24, no. 6 (August 2019): 393–404. https://doi.org/10.3851/imp3331.
Vannappagari V, Ragone L, Henegar C, van Wyk J, Brown D, Demarest J, et al. Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy. 2019 Aug;24(6):393–404.
Vannappagari, Vani, et al. “Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review.” Antiviral Therapy, vol. 24, no. 6, SAGE Publications, Aug. 2019, pp. 393–404. Crossref, doi:10.3851/imp3331.
Vannappagari V, Ragone L, Henegar C, van Wyk J, Brown D, Demarest J, Quercia R, Clair MS, Underwood M, Gatell JM, de Ruiter A, Aboud M. Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy. SAGE Publications; 2019 Aug;24(6):393–404.
Published In
Antiviral Therapy
DOI
EISSN
2040-2058
ISSN
1359-6535
Publication Date
August 2019
Volume
24
Issue
6
Start / End Page
393 / 404
Publisher
SAGE Publications
Related Subject Headings
- Virology
- 1108 Medical Microbiology
- 1103 Clinical Sciences
- 0605 Microbiology